Approvals/TGA/OCTREOTIDE DEPOT octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack

Approved

STANDARD

OCTREOTIDE DEPOT octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack

Teva Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b99512fa7224987a
Product Name: OCTREOTIDE DEPOT octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack
Artg Id: 321281
Artg Name: OCTREOTIDE DEPOT octreotide (as acetate) 30 mg modified release injection vial plus diluent prefilled syringe composite pack
Sponsor: Teva Pharma Australia Pty Ltd
Company Detail Path: /organization/teva-pharma-australia-pty-ltd
Artg Date: 2020-11-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3e183e0fd0d8718a4b8977508513b9f7.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6981ae1f7ba1f96d40e6a3dc831ebb66.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b99512fa7224987a

Type

Standard